scPharmaceuticals Inc.
SCPH
$4.85
$0.286.13%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 41.09M | 57.90M | 76.68M | 92.63M | 38.88M |
Total Receivables | 19.41M | 13.85M | 11.72M | 9.22M | 6.12M |
Inventory | 14.57M | 14.14M | 13.90M | 18.11M | 15.31M |
Prepaid Expenses | 3.65M | 3.46M | 3.55M | 3.37M | 2.33M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 78.73M | 89.35M | 105.85M | 123.33M | 62.63M |
|
|||||
Total Current Assets | 78.73M | 89.35M | 105.85M | 123.33M | 62.63M |
Net Property, Plant & Equipment | 1.22M | 1.29M | 1.33M | 1.38M | 1.36M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 303.00K | 322.00K | 341.00K | 359.00K | 1.47M |
Total Assets | 80.26M | 90.96M | 107.52M | 125.07M | 65.46M |
|
|||||
Total Accounts Payable | 4.03M | 4.99M | 3.88M | 5.00M | 5.29M |
Total Accrued Expenses | 14.80M | 9.84M | 9.73M | 9.87M | 7.40M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 264.00K | 254.00K | 239.00K | 231.00K | 190.00K |
Total Finance Division Other Current Liabilities | 1.34M | 1.23M | 1.02M | 162.00K | 47.00K |
Total Other Current Liabilities | 1.34M | 1.23M | 1.02M | 162.00K | 47.00K |
Total Current Liabilities | 20.43M | 16.31M | 14.88M | 15.26M | 12.93M |
|
|||||
Total Current Liabilities | 20.43M | 16.31M | 14.88M | 15.26M | 12.93M |
Long-Term Debt | 51.20M | 51.05M | 51.35M | 51.10M | 39.99M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 984.00K | 1.05M | 1.10M | 1.17M | 1.18M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 28.96M | 27.68M | 26.87M | 26.83M | 2.10M |
Total Liabilities | 101.57M | 96.09M | 94.20M | 94.36M | 56.21M |
|
|||||
Common Stock & APIC | 382.94M | 381.11M | 379.81M | 378.36M | 321.79M |
Retained Earnings | -404.26M | -386.24M | -366.49M | -347.65M | -312.54M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -21.32M | -5.13M | 13.32M | 30.71M | 9.25M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -21.32M | -5.13M | 13.32M | 30.71M | 9.25M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -21.32M | -5.13M | 13.32M | 30.71M | 9.25M |
|